Literature DB >> 15604544

Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma.

R Dummer1, R Panizzon, P H Bloch, G Burg.   

Abstract

Melanoma is the most common lethal cutaneous neoplasm. In order to harmonize treatment and follow-up of melanoma patients, guidelines for the management of melanoma in Switzerland have been inaugurated in 2001. These have been approved by all Swiss medical societies involved in the care of melanoma patients. New data necessitated changes concerning the safety margins (reduction to maximally 2 cm) and modifications of the recommendations of follow-up.

Entities:  

Mesh：

Year:  2005        PMID： 15604544     DOI： 10.1159/000081482

Source DB:  PubMed          Journal:  Dermatology        ISSN： 1018-8665            Impact factor:   5.366


  13 in total

Review 1.  Strategies for early melanoma detection: Approaches to the patient with nevi.

Authors:  Agnessa Gadeliya Goodson; Douglas Grossman
Journal:  J Am Acad Dermatol       Date:  2009-05       Impact factor: 11.527

2.  2-Deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computed tomography in the management of melanoma.

Authors:  A Iagaru; A Quon; D Johnson; S S Gambhir; I R McDougall
Journal:  Mol Imaging Biol       Date:  2007 Jan-Feb       Impact factor: 3.488

3.  Evaluation of multiple serum markers in advanced melanoma.

Authors:  Angel Díaz-Lagares; Estíbaliz Alegre; Ainhoa Arroyo; María González-Cao; Maria E Zudaire; Santiago Viteri; Salvador Martín-Algarra; Alvaro González
Journal:  Tumour Biol       Date:  2011-08-20

Review 4.  Long-term follow-up for melanoma patients: is there any evidence of a benefit?

Authors:  Natasha M Rueth; Kate D Cromwell; Janice N Cormier
Journal:  Surg Oncol Clin N Am       Date:  2015-01-24       Impact factor: 3.495

Review 5.  Variability in melanoma post-treatment surveillance practices by country and physician specialty: a systematic review.

Authors:  Kate D Cromwell; Merrick I Ross; Yan Xing; Jeffrey E Gershenwald; Richard E Royal; Anthony Lucci; Jeffrey E Lee; Janice N Cormier
Journal:  Melanoma Res       Date:  2012-10       Impact factor: 3.599

6.  Tumour assessment in advanced melanoma: value of FDG-PET/CT in patients with elevated serum S-100B.

Authors:  Klaus Strobel; Jeannine Skalsky; Victor Kalff; Katrin Baumann; Burkhardt Seifert; Helen Joller-Jemelka; Reinhard Dummer; Hans C Steinert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-03-28       Impact factor: 9.236

7.  minSKIN does a multifaceted intervention improve the competence in the diagnosis of skin cancer by general practitioners? Study protocol for a randomised controlled trial.

Authors:  Nina Badertscher; Thomas Rosemann; Ryan Tandjung; Ralph P Braun
Journal:  Trials       Date:  2011-06-30       Impact factor: 2.279

8.  Long-term pegylated interferon-alpha and its potential in the treatment of melanoma.

Authors:  Reinhard Dummer; Joanna Mangana
Journal:  Biologics       Date:  2009-07-13

Review 9.  Biomarkers in melanoma.

Authors:  H Gogas; A M M Eggermont; A Hauschild; P Hersey; P Mohr; D Schadendorf; A Spatz; R Dummer
Journal:  Ann Oncol       Date:  2009-08       Impact factor: 32.976

Review 10.  Staging of cutaneous melanoma.

Authors:  P Mohr; A M M Eggermont; A Hauschild; A Buzaid
Journal:  Ann Oncol       Date:  2009-08       Impact factor: 32.976
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.